Indicated for: cachexia; breast or endometrial cancer
Route of administration: oral
Substance: megestrol (antineoplastic agent)
ATC: L02AB01 (Antineoplastic and immunomodulating agents | Hormones and related agents | Progestogens)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Megestrol is a medication primarily used to treat breast cancer and endometrial cancer. It is also used to stimulate appetite and prevent weight loss in patients with chronic illnesses such as AIDS or advanced cancer.
This drug belongs to the class of progestins and works by altering hormonal balance, inhibiting the growth of hormone-sensitive cancer cells. Additionally, megestrol can help increase body mass by stimulating appetite.
Megestrol is available in tablet or oral suspension form, and the dosage is adjusted based on the condition being treated and the patient's response. Treatment may have side effects such as weight gain, fluid retention, mood changes, or gastrointestinal disturbances.
Patients taking megestrol should be regularly monitored by their doctor, especially if they have a history of thrombosis or other cardiovascular conditions. Pregnant or breastfeeding women should not use this medication.